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Results: Query revealed 567 total amputations, of which 198 were major and 137 were repeated amputations. Demographics for the entire cohort demonstrated an average age of 56.2 years, 87% nonwhite, 70% indigent, 86% diabetic, and 8% requiring dialysis. Prevalence of smoking and hypertension decreased over time (P < .05) and was the only significant change in patient risk factors. Overall, the ratio of major/total amputations (Fig 1) decreased from 48% to 22%, becoming statistically significant (P < .05) after 2015. A statistically significant difference in total amputations per year was not discovered. Major amputation rates remained highest among uninsured patients (P < .05) compared with public and private insurance. No statistically significant change occurred in patient payer mix. No patient risk or fiscal factors were predictive of repeated amputation. Vascular surgeons performed 14% of amputations in the entire cohort. Population analysis (Fig 2) of the top 10 amputation-prevalent ZIP codes representing 28% of all amputations revealed annual income per person of $14,900, 34.2% black, 51.2% Hispanic, 59% employed, 32% uninsured, 37% public insurance, and 32% private insurance.
Conclusions: In resource-limited environments, threatened limbs may be managed by specialist and nonspecialist providers who are frontline and greater in number. Inclusion of sparse specialists into only a limb salvage collaborative did not achieve major limb amputation prevention in this study, and only after inclusion of all providers performing amputation did a statistically significant shift from major to minor amputation occur. Further reduction of major and minor amputation may be challenging in this population, given the limitations in system and patient resources, and will likely require alternative paradigms to existing models.
Author Disclosures: V. Aribindi: Nothing to disclose; J. Chung: Nothing to disclose; R. Gilani: Nothing to disclose; J. L. Mills: Nothing to disclose; M. Montero-Baker: Nothing to disclose; E. Poythress: Nothing to disclose; S. Todd: Nothing to disclose. Objective: The TransAtlantic Inter-Society Consensus (TASC) guidelines for the management of peripheral arterial disease provide recommendations for diagnosis and treatment. An updated infrapopliteal TASC classification was created to adapt to modern endovascular management of tibial lesions; however, long-term outcomes using this updated tibial TASC classification system are not yet established.
Methods: We performed a retrospective institutional review of consecutive patients who underwent successful lower extremity tibial artery interventions from 2005 to 2010. Former and updated tibial TASC classifications were assigned on the basis of review of initial lower extremity arteriograms for target tibial vessels. We used Cox regression to compare long-term freedom from reintervention, major amputation, or primary restenosis (RAS).
Results: During this study period, 322 patients underwent tibial artery angioplasty with or without stenting; 185 patients (57%) had multilevel interventions and 73 (22%) were not bypass candidates. Based on former tibial TASC guidelines, 49 patients (15%) were classified with TASC A lesions, 69 (21%) with TASC B lesions, 85 (26%) with TASC C lesions, and 119 (37%) with TASC D lesions. Using the updated tibial TASC guidelines, the number of tibial lesions classified as TASC A and B lesions increased to 75 (23%) and 126 patients (39%), respectively, and the number of TASC C and D lesions decreased to 61 (19%) and 76 (19%), respectively. Freedom from RAS at 3 years using former TASC A, B, C, and D classification was 53%, 39%, 36%, and 19%, respectively (P < .001). Freedom from RAS using updated tibial TASC A, B, C, and D classification was 46%, 40%, 13%, and 21%, respectively (P ¼ .002). However, after adjustment for baseline patient and procedural characteristics, neither former nor updated TASC classifications were associated with a higher risk of RAS compared with TASC A lesions (former TASC D: hazard ratio, 2.2 [0.8-5.8; P ¼ .11]; updated TASC D: hazard ratio, 1.4 [0.5-3.9; P ¼ .51]; Figs 1 and 2).
Conclusions: The updated tibial TASC classification has resulted in a down-classification of tibial lesions and therefore broader indications for endovascular intervention. However, this new tibial TASC classification system still does not adequately model a patient's long-term risk of limb events. Methods: By use of statewide data, all patients were identified with lower extremity ulcers and a diagnosis of peripheral arterial disease who underwent a revascularization procedure from 2005 to 2013. Propensity scores were formulated from baseline characteristics of the patients. Inverse probability weighting was used within Kaplan-Meier analysis to determine AFS and time to reintervention for open vs endovascular treatment. Cox proportional hazards modeling was used to adjust for access to care and hospital revascularization experience.
Results: A total of 16,800 patients were identified. Open surgical bypass was the initial treatment of 5970 (36%) patients, whereas 10,830 (64%) underwent endovascular interventions. Patients in the endovascular group were slightly younger compared with the open group (70 vs 72 years; standard deviation, 12 years; P < .001). Endovascular patients were more likely to have renal failure (36% vs 24%) and coronary artery disease (34% vs 32%), whereas patients in the open bypass group were more likely to have diabetes mellitus (30% vs 44%; all P values < .05). After propensity weighting, open first treatment was associated with lower rates of reintervention (hazard ratio [HR] , 0.87; 95% confidence interval [CI], 0.83-0.91); however, surgery first was associated with a lower AFS (HR, 1.16; 95% CI, 1.12-1.2; Fig) . Initial treatment at a high-volume center was associated with improved AFS compared with medium-volume (HR, 1.3; CI, 1.21-1.36) or low-volume (HR, 1.2; CI, 1.1-1.3) centers.
Conclusions: Patients with critical limb ischemia have multiple comorbidities, and initial surgical bypass is associated with poorer quality of AFS compared with an endovascular first approach. Treatment in high-volume centers improves AFS. This may be due to improved resources at high-volume centers. Objective: Drug-eluting stents (DESs) are highly efficacious for interventions on coronary saphenous vein graft bypasses, with improved patency over angioplasty and bare-metal stenting. We have used these stents in failing lower extremity bypass grafts with aggressive or refractory stenotic lesions and present the experience at a single institution.
Methods: All patients who underwent DES (coronary stent) placement in an infrainguinal vein bypass graft from 2012 to 2017 were identified through operative records. Demographic, treatment, and follow-up data were extracted retrospectively from the medical record. Wilcoxon signed rank and rank sum tests were used to compare the reintervention-free intervals for paired and unpaired data, respectively.
Results: A total of 22 DESs were placed in 18 lower extremities. Median age at the time of bypass was 64 years (range, 49-84 years). All patients required an infrageniculate distal anastomosis, and great saphenous vein was used. After bypass, patients underwent a mean of 3.3 6 2.4 interventions. Fortyfive percent of reinterventions were for recurrent ischemic symptoms (n ¼ 27); 55% were reintervened on for asymptomatic but concerning surveillance duplex ultrasound findings. Reinterventions included plain balloon angioplasty (percutaneous transluminal angioplasty [PTA] , n ¼ 27), drugcoated balloon angioplasty (n ¼ 6), cutting balloon angioplasty (n ¼ 5), bare-metal stenting (n ¼ 8), and DES placement. DESs were placed for initial (n ¼ 13) or recurrent (n ¼ 9) stenoses. Half of all DESs were placed immediately after PTA that had yielded unsatisfactory residual stenosis on completion angiography. All attempted DES placements were technically successful and required no additional interventions at time of placement. The median time to reintervention or time to last available duplex ultrasound examination demonstrating patency (if no additional reintervention occurred) trended in favor of DES (7.7 months; interquartile range [IQR], 3.7-13.8 months) over standard endovascular interventions (4.8 months; 
